NCT07228689
AI for Onsite Cytology Evaluation in Endoscopic Ultrasound
Active, Not Recruiting
Not specifiedAges 18+ObservationalOrlando Health, Inc.Investigator-initiated
~136 participants
Updated 2026-06-30 on ClinicalTrials.gov
What's tested:EUS-guided fine needle biopsy
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Diagnostic adequacy at rapid onsite evaluation
Measured over 1 day
Conditions
Where it's being run
1 sites across 1 statesFlorida1
Study leadership
- Ji Young Bang, MD MPH · PRINCIPAL_INVESTIGATOR · Orlando Health
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Age 18 years old or greater
Patients undergoing EUS-guided fine needle biopsy of solid mass lesions in the gastrointestinal tract
Exclusion
Age less than 18 years
Patients not undergoing sampling of solid mass lesions at EUS
Patients with cystic lesions in the gastrointestinal tract
What this trial measures
- Diagnostic adequacy at rapid onsite evaluation1 day
The ability of the AI systems to interpret specimen adequacy on cytology images